Litigation Details for Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd. (D. Del. 2019)

Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd. (D. Del. 2019)

Docket		Date Filed	2019-10-11
Court	District Court, D. Delaware	Date Terminated	2022-10-26
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	Plaintiff	Referred To
Patents	10,010,533; 10,307,419; 6,562,375; 7,888,362; 8,349,840; 8,618,109; 9,265,831; 9,572,796; 9,572,797; 9,839,637
Link to Docket	External link to docket

Details for Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd. (D. Del. 2019)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2021-07-27	126	Opinion - Memorandum Opinion	one of the five patents-in-suit, U.S. Patent No. 10,307,419 (the '" 419 patent"). The parties…; It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent "specification…;Plaintiffs") allege infringement of five patents against 18 pharmaceutical manufacturers seeking… Plaintiffs' REXULTI® tablets before the patents expire. (D.I. 71 ; D.I. 92 at 1) 1 REXULTI® is	External link to document
2020-05-19	15	Redacted Document	asserted U.S. Patent Nos. 9,265,831; 9,572,796; 9,572,797; and 10,010,533. Case…agree that Claim 1 of U.S. Patent No. 9,572,796 (“the ’796 patent”), shown below in relevant…from the patent disclosures is that a skilled artisan would understand the patents to disclose…on the Pleadings of Noninfringement of the '419 Patent by Biophore India Pharmaceuticals Private Ltd.,… Slayback Pharma LLC for infringing four patents covering Eagle’s brand name bendamustine	External link to document